Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to assess the safety of low-dose levonorgestrel (LNG) (12μg/24h, initial in vitro release rate), delivered locally by an intrauterine contraceptive system in adolescents over 1 year of treatment, including insertion and removal procedures.
Critère d'inclusion
- Contraception